Literature DB >> 16411896

MITF mediates cAMP-induced protein kinase C-beta expression in human melanocytes.

Hee-Young Park1, Christina Wu, Laurie Yonemoto, Melissa Murphy-Smith, Heng Wu, Christina M Stachur, Barbara A Gilchrest.   

Abstract

The cAMP-dependent pathway up-regulates MITF (microphthalmia-associated transcription factor), important for key melanogenic proteins such as tyrosinase, TRP-1 (tyrosinase-related protein 1) and TRP-2. We asked whether MITF is also a key transcription factor for PKC-beta (protein kinase C-beta), required to phosphorylate otherwise inactive tyrosinase. When paired cultures of human melanocytes were treated with isobutylmethylxanthine, known to increase intracellular cAMP, both protein and mRNA levels of PKC-beta were induced by 24 h. To determine whether MITF modulates PKC-beta expression, paired cultures of human melanocytes were transfected with dn-MITF (dominant-negative MITF) or empty control vector. By immunoblotting, PKC-beta protein was reduced by 63+/-3.7% within 48 h. Co-transfection of an expression vector for MITF-M, the MITF isoform specific for pigment cells, or empty control vector with a full-length PKC-beta promoter-CAT (chloramphenicol acetyltransferase) reporter construct (PKC-beta/CAT) into Cos-7 cells showed >60-fold increase in CAT activity. Melanocytes abundantly also expressed MITF-A, as well as the MITF-B and MITF-H isoforms. However, in contrast with MITF-M, MITF-A failed to transactivate co-expressed PKC-beta/CAT or CAT constructs under the control of a full-length tyrosinase promoter. Together, these results demonstrate that MITF, specifically MITF-M, is a key transcription factor for PKC-beta, linking the PKC- and cAMP-dependent pathways in regulation of melanogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16411896      PMCID: PMC1462691          DOI: 10.1042/BJ20051388

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  57 in total

Review 1.  Signaling pathways mediating melanogenesis.

Authors:  H Y Park; B A Gilchrest
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  1999-11       Impact factor: 1.770

Review 2.  Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage.

Authors:  C R Goding
Journal:  Genes Dev       Date:  2000-07-15       Impact factor: 11.361

3.  Microphthalmia transcription factor: a sensitive and specific marker for malignant melanoma in cytologic specimens.

Authors:  C C Dorvault; K N Weilbaecher; H Yee; D E Fisher; L A Chiriboga; Y Xu; D C Chhieng
Journal:  Cancer       Date:  2001-10-25       Impact factor: 6.860

4.  Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas.

Authors:  J Vachtenheim; H Novotná
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  1999-11       Impact factor: 1.770

5.  Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: a result of transformation or differentiation?

Authors:  E M Gilhooly; M Morse-Gaudio; L Bianchi; L Reinhart; D P Rose; J M Connolly; J A Reed; A P Albino
Journal:  Melanoma Res       Date:  2001-08       Impact factor: 3.599

6.  Molecular cloning of cDNA encoding a novel microphthalmia-associated transcription factor isoform with a distinct amino-terminus.

Authors:  N Fuse; K i Yasumoto; K Takeda; S Amae; M Yoshizawa; T Udono; K Takahashi; M Tamai; Y Tomita; M Tachibana; S Shibahara
Journal:  J Biochem       Date:  1999-12       Impact factor: 3.387

Review 7.  Diagnostic utility of microphthalmia transcription factor in malignant melanoma and other tumors.

Authors:  K L Chang; A L Folpe
Journal:  Adv Anat Pathol       Date:  2001-09       Impact factor: 3.875

8.  Ectopic expression of MITF, a gene for Waardenburg syndrome type 2, converts fibroblasts to cells with melanocyte characteristics.

Authors:  M Tachibana; K Takeda; Y Nobukuni; K Urabe; J E Long; K A Meyers; S A Aaronson; T Miki
Journal:  Nat Genet       Date:  1996-09       Impact factor: 38.330

Review 9.  The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation.

Authors:  R D Cone; D Lu; S Koppula; D I Vage; H Klungland; B Boston; W Chen; D N Orth; C Pouton; R A Kesterson
Journal:  Recent Prog Horm Res       Date:  1996

10.  Alpha-melanocyte stimulating hormone-induced pigmentation is blocked by depletion of protein kinase C.

Authors:  H Y Park; V Russakovsky; Y Ao; E Fernandez; B A Gilchrest
Journal:  Exp Cell Res       Date:  1996-08-25       Impact factor: 3.905

View more
  25 in total

1.  Suppression of melanin production by expression of HSP70.

Authors:  Tatsuya Hoshino; Minoru Matsuda; Yasuhiro Yamashita; Masaya Takehara; Masayo Fukuya; Kazutaka Mineda; Daisuke Maji; Hironobu Ihn; Hiroaki Adachi; Gen Sobue; Yoko Funasaka; Tohru Mizushima
Journal:  J Biol Chem       Date:  2010-02-22       Impact factor: 5.157

2.  Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo.

Authors:  Kirsten C Webb; Jonathan M Eby; Vidhya Hariharan; Claudia Hernandez; Rosalie M Luiten; I Caroline Le Poole
Journal:  Exp Dermatol       Date:  2014-07-10       Impact factor: 3.960

3.  Reduced MiR-675 in exosome in H19 RNA-related melanogenesis via MITF as a direct target.

Authors:  Nan-Hyung Kim; Soo-Hyun Choi; Chang-Hyun Kim; Chang Hoon Lee; Tae Ryong Lee; Ai-Young Lee
Journal:  J Invest Dermatol       Date:  2013-11-11       Impact factor: 8.551

4.  Angiotensin II stimulates melanogenesis via the protein kinase C pathway.

Authors:  Li-Hong Liu; Xin Fan; Zhi-Kuan Xia; Xu-Xi An; Rong-Ya Yang
Journal:  Exp Ther Med       Date:  2015-08-14       Impact factor: 2.447

5.  Association detection between genetic variants in the microRNA binding sites of toll-like receptors signaling pathway genes and bladder cancer susceptibility.

Authors:  Sihang Cheng; Jiaming Liu; Yonggang Zhang; Yifei Lin; Qinyu Liu; Hong Li; Jin Huang; Peng Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 6.  Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization.

Authors:  Stanca A Birlea; Gertrude-E Costin; Dennis R Roop; David A Norris
Journal:  Med Res Rev       Date:  2016-12-28       Impact factor: 12.944

7.  Role of BMP-4 and Its Signaling Pathways in Cultured Human Melanocytes.

Authors:  Hee-Young Park; Christina Wu; Mina Yaar; Christina M Stachur; Marita Kosmadaki; Barbara A Gilchrest
Journal:  Int J Cell Biol       Date:  2009-12-30

Review 8.  Ion transport in pigmentation.

Authors:  Nicholas W Bellono; Elena V Oancea
Journal:  Arch Biochem Biophys       Date:  2014-07-14       Impact factor: 4.013

9.  Metformin: a potential drug to treat hyperpigmentation disorders.

Authors:  Elisabeth S Belisle; Hee-Young Park
Journal:  J Invest Dermatol       Date:  2014-10       Impact factor: 8.551

10.  Agouti protein, mahogunin, and attractin in pheomelanogenesis and melanoblast-like alteration of melanocytes: a cAMP-independent pathway.

Authors:  Tokimasa Hida; Kazumasa Wakamatsu; Elena V Sviderskaya; Andrew J Donkin; Lluis Montoliu; M Lynn Lamoreux; Bin Yu; Glenn L Millhauser; Shosuke Ito; Gregory S Barsh; Kowichi Jimbow; Dorothy C Bennett
Journal:  Pigment Cell Melanoma Res       Date:  2009-05-26       Impact factor: 4.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.